Clinical trial
A Controlled Evaluation of the Spectra Optia® Apheresis System's Granulocyte / Polymorphonuclear (PMN) Cell Collection Procedure
NCT01805180 is registered in ClinicalTrials.gov with Terumo BCT as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Controlled Evaluation of the Spectra Optia® Apheresis System's Granulocyte / Polymorphonuclear (PMN) Cell Collection Procedure
- Lead sponsor
- Terumo BCT
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- July 31, 2013
- Enrollment
- 42 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
granulocyte/ polymorphonuclear cells